Alx Oncology Holdings reported cash from operations of -$16.06M and free cash flow of -$16.07M for the quarter ended Jun 2026, up 31.4% year over year. This cash flow statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||
| Net Income | -24.57M | -28.46M | -25.36M | -34.44M | -35.31M | -30.64M | -31.83M | -37.37M | -50.99M | -45.44M | -38.42M | -42.05M | -30.71M | -29.16M | -32.38M | -25.95M | -22.14M | -22.83M | -19.57M | -16.81M | |||||||||
| Share-based Compensation | 4.19M | 3.26M | 0.50M | 0.49M | 6.21M | 6.29M | 6.35M | 0.11M | 6.96M | 6.72M | 0.24M | 0.86M | 6.95M | 5.86M | 5.22M | 2.14M | 2.52M | 2.71M | 0.67M | 2.68M | |||||||||
| Asset Writedowns and Impairment | 0.03M | ||||||||||||||||||||||||||||
| Cash from Operations | -24.86M | -17.49M | -20.67M | -17.00M | -30.88M | -20.67M | -27.82M | -31.71M | -31.16M | -39.68M | -37.92M | -26.57M | -25.38M | -32.05M | -24.66M | -23.41M | -17.09M | -18.98M | -18.65M | -16.06M | |||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.11M | 0.00M | 0.36M | 0.68M | 1.11M | 1.65M | 1.84M | 1.88M | 1.55M | 1.32M | 1.05M | 0.74M | 0.53M | 0.31M | 0.22M | 0.19M | 0.20M | 0.34M | |||||||||||
| Amortization of Deferred Charges | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | |||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.01M | 0.03M | 0.06M | 0.08M | 0.10M | 0.10M | 0.21M | 0.21M | 0.21M | 0.21M | 0.21M | 0.22M | 0.22M | 0.21M | 0.21M | 0.19M | 0.15M | 0.15M | 0.15M | 0.09M | |||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||
| Change in Account Payables | -2.18M | -0.33M | 1.55M | 3.56M | -3.06M | 2.45M | 1.77M | -5.71M | 8.89M | -4.48M | -2.33M | 1.88M | -0.19M | -3.39M | -0.56M | 0.96M | 1.68M | -1.67M | -1.21M | -0.77M | |||||||||
| Change in Accured Expenses | 1.12M | 0.97M | -1.30M | 4.07M | 3.65M | 0.61M | -5.55M | 3.75M | 8.29M | 4.73M | -1.08M | 4.74M | -5.39M | -10.89M | -0.10M | -1.92M | 6.17M | -2.15M | -3.01M | 1.36M | |||||||||
| Other Working Capital Changes | -0.23M | -0.40M | 1.58M | -2.15M | 3.19M | -1.14M | -0.19M | 2.15M | 2.35M | -6.66M | 4.50M | 1.56M | -7.64M | -0.50M | -1.89M | 0.87M | -0.48M | -0.40M | -0.70M | -0.23M | |||||||||
| Investing Activities | |||||||||||||||||||||||||||||
| Capital Expenditures | 0.40M | 0.26M | 0.59M | 0.26M | 0.19M | 0.39M | 0.69M | 1.74M | -1.30M | 0.15M | 0.15M | 0.09M | 0.15M | 0.06M | 0.06M | 0.05M | 0.06M | 0.05M | 0.05M | 0.02M | |||||||||
| Change in Acquisitions & Divestments | 50.50M | 72.30M | 115.19M | 54.48M | 64.40M | 58.49M | 57.91M | 63.96M | 34.55M | 37.69M | 43.48M | 47.77M | 25.89M | 17.26M | 19.50M | 12.25M | |||||||||||||
| Cash from Investing Activities | -0.40M | -4.52M | -183.92M | -76.13M | 13.70M | 10.94M | 42.30M | 6.21M | 12.81M | -16.67M | 26.47M | 0.91M | 25.69M | 33.18M | 27.64M | 22.32M | 21.39M | 11.23M | -105.04M | 6.52M | |||||||||
| Financing Activities | |||||||||||||||||||||||||||||
| Other financing activities | 0.54M | 0.53M | 0.18M | 0.15M | 0.01M | 0.22M | 0.18M | 0.24M | 0.86M | 0.53M | 0.01M | 0.67M | 0.07M | ||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||||||
| Long-Term Debt Issuances | 150.00M | ||||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.43M | 0.02M | 0.24M | 0.30M | 3.16M | 5.03M | |||||||||||||||||||||||
| Net Equity Issued and Repurchased | 3.02M | 26.20M | 0.07M | 0.36M | 0.37M | 1.32M | 0.01M | ||||||||||||||||||||||
| Misc. | |||||||||||||||||||||||||||||
| Cash from Financing Activities | 0.44M | 0.52M | 0.08M | 0.42M | -0.14M | 9.49M | -0.11M | 0.34M | -0.11M | 59.17M | 3.09M | 27.15M | 0.25M | 0.33M | 0.07M | -0.22M | -0.16M | 0.68M | 139.59M | 0.14M | |||||||||
| Change in Cash | -24.82M | -21.48M | -204.51M | -92.71M | -17.32M | -0.23M | 14.37M | -25.16M | -18.45M | 2.82M | -8.37M | 1.49M | 0.57M | 1.47M | 3.05M | -1.31M | 4.14M | -7.07M | 15.91M | -9.40M | |||||||||
| Free Cash Flow | -25.25M | -17.75M | -21.26M | -17.25M | -31.07M | -21.06M | -28.51M | -33.45M | -29.86M | -39.83M | -38.07M | -26.66M | -25.52M | -32.11M | -24.72M | -23.45M | -17.15M | -19.03M | -18.70M | -16.07M | |||||||||
| Net Cash Flow | -24.82M | -21.48M | -204.51M | -92.71M | -17.32M | -0.23M | 14.37M | -25.16M | -18.45M | 2.82M | -8.37M | 1.49M | 0.57M | 1.47M | 3.05M | -1.31M | 4.14M | -7.07M | 15.91M | -9.40M |